Abbvie Inc
NYSE: ABBV
$177.08
-$1.42 (-0.8%)
Real Time Data Delayed 15 Min.
ABBV Articles
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and...
Published:
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
These five stock income ideas are rated Buy by major Wall Street firms and offer consistent and dependable dividends. They are good choices for income-seeking investors with a higher risk tolerance.
Published:
24/7 Wall St. has put together a preview of AbbVie, American Airlines, Netflix, Starbucks and some of the other most prominent earnings reports due in this truncated trading week.
Published:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain FDA approval, but the new drug will compete with other recently released treatments for...
Published:
Last Updated:
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, AMD, AT&T, Broadcom, Energy Transfer, Ford, Fortinet, Intel, Intelsat, Shake Shack and T-Mobile.
Published:
Last Updated:
Here are five health-care-related stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross.
Published:
Last Updated:
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
24/7 Wall St. has put together a preview of AT&T, Facebook, T-Mobile and the other most prominent earnings reports due this week.
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Here are 20 companies that should offer investors who are retired or near retirement some added income to help make their golden years safe and sound.
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.